Roth/MKM Downgrades Capricor Therapeutics (CAPR) to Neutral

July 27, 2026 3:47 PM

Roth/MKM analyst Boobalan Pachaiyappan downgraded Capricor Therapeutics (NASDAQ: CAPR) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found